Shareholders’ Equity (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended
	Jul. 31, 2017	Jun. 30, 2020	May 02, 2020	Dec. 31, 2019
Entity Listings [Line Items]
Preferred shares, shares authorized		2,000,000		2,000,000
Preferred shares, shares issued		0		0
Preferred shares, shares outstanding		0		0
Common stock, shares authorized		250,000,000		250,000,000
Common stock, no par value		$ 0		$ 0
Common stock, issued		149,831,347		149,804,284
Common stock, outstanding		149,831,347		149,804,284
Cell Cure Warrants [Member] | Consultants [Member]
Entity Listings [Line Items]
Warrants issued to purchase ordinary shares		13,738
Warrants expiring period, description		expire in October 2020 and January 2024
Hadasit Bio-Holdings Ltd. [Member]
Entity Listings [Line Items]
Warrants issued to purchase ordinary shares	24,566
Warrants exercise price per share	$ 40.5359
Warrant expiration date	July 2022
Asterias Biotherapeutics, Inc. [Member]
Entity Listings [Line Items]
Warrants issued to purchase ordinary shares		1,089,900
Warrants exercisable term		30 days
Warrants exercise price per share		$ 6.15
Warrant expiration date		May 13, 2021
Maximum [Member] | Cell Cure Warrants [Member] | Consultants [Member]
Entity Listings [Line Items]
Warrants exercise price per share		$ 40.00
Minimum [Member] | Cell Cure Warrants [Member] | Consultants [Member]
Entity Listings [Line Items]
Warrants exercise price per share		$ 32.02
Cantor Fitzgerald And Co Member [Member] | 2017 Sales Agreement [Member]
Entity Listings [Line Items]
Share value available for sale		$ 0
Percentage of commission payable		3.00%
Cantor Fitzgerald And Co Member [Member] | 2017 Sales Agreement [Member] | Maximum [Member]
Entity Listings [Line Items]
Aggregate offering price			$ 25,000,000